China Regenerative Medicine International Ltd banner
C

China Regenerative Medicine International Ltd
HKEX:8592

Watchlist Manager
China Regenerative Medicine International Ltd
HKEX:8592
Watchlist
Price: 0.98 HKD Market Closed
Market Cap: HK$279.7m

China Regenerative Medicine International Ltd
Investor Relations

China Regenerative Medicine International Ltd. is an investment holding company, which engages in in research and development of medical and healthcare products. Along with subsidiaries, the Company operates its business through four segments. The Medical Equipment segment is involved in trading of medical equipments. The Tissue Engineering segment is involved in production and sale of tissue engineering products. The Cosmetic and Others segment is involved in production and sales of cosmetic, healthcare and other products. The Stem Cell segment is involved in research of cellular and stem cell therapy, sales and distribution of stem cell medical equipment, as well as the provision of other services.

Show more
Loading
8592
Hang Seng (Hong Kong)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Chuang Wang
CEO, Executive Chairman & Compliance Officer
No Bio Available
Mr. Po Tin Wong
CFO & Company Secretary
No Bio Available
Dr. Jinnan Zhang
Chief Technology Officer
No Bio Available

Contacts

Address
Suite 2310-2318, Miramar Tower, 132 Nathan Road, Tsim Sha Tsui, Kowloon
Contacts
+85239668388.0
www.crmi.hk
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett